Journal Finder

Methods X publishes the small but important customizations you make to methods every day. By releasing the hidden gems from your lab book, you can get credit for the time, effort and money you've put in to making methods work for you. And because it is open access, it is even more visible and citable, giving your work the exposure it deserves.

MethodsX provides an outlet for technical information that can be useful for others working in the same field, and help them save time in their own research, while giving you the deserved credit for your efforts. Since this is relevant for any field doing experimental work, MethodsX welcomes submissions from all research areas.

MethodsX puts the technical aspects of your work into the spotlight. Publish essential details of the tweaks you have made to a method, without spending time on writing up a traditional article, with detailed background and contextual information. Your MethodsX article showcases the work you've done to customize a method. It's that simple.

A MethodsX article features:

• an abstract to outline the customization
• a graphical abstract visual to illustrate what you've done
• the method(s) in sufficient detail to help people replicate it, including any relevant figures, tables etc
• up to 25 references to the original description of the method you're using

While keeping focused on the technical aspect of the work, evidence of the efficiency of the method and/or comparison with pre- existing protocols needs to be provided. This should be immediately evident to the reader.

To see some examples please click http://www.sciencedirect.com/science/journal/22150161here

Before submitting, please make sure your manuscript complies with the following criteria:

1. The article is written in standard English and clearly understandable
2. The manuscript adheres to the MethodsX format, see the http://www.elsevier.com/journals/methodsx/2215-0161/guide-for-authorsauthor guidelines
3. Control data supporting the claims made are included: evidence of the efficiency of the method and/or comparison with pre- existing protocols is provided
4. The method should describe a change over established practices

Note that manuscripts not adhering to the above points may be rejected without full peer review.

Please use the MethodsX http://cdn.elsevier.com/promis_misc/MEX_ArticleTemplate.docxarticle template when compiling your manuscript.

For any questions contact us at: MethodsX@elsevier.com

Microscopy Research and Technique ( MRT ) publishes articles on all aspects of advanced microscopy in the biological, clinical, chemical, and materials sciences. Original research as well as technical papers dealing with the various subsets of microscopy are welcomed. This includes electron microscopy (transmission electron microscopy, scanning electron microscopy, analytical microscopy [X-ray, EELS, Auger, etc.]), light microscopy (confocal microscopy, video microscopy, fluorescence microscopy, light microscopy combined Raman spectroscopy, fourier transform infra red spectroscopy [FTIR], etc.), scanning probe microscopy (AFM, STM, etc.), micro magnetic resonance imaging, micro acoustic imaging, as well as image analysis, quantitative morphology, and all other forms of leading edge microscopic imaging and image analysis. It is expected that manuscripts submitted for consideration will clearly present the scientific question, justify the type of specimen(s) used in the experiment, explicitly describe the methods utilized, employ proper statistics, present previously unpublished data, discuss whether the experiment has answered the proposed question, compare the results with those in salient published literature, and conform to MRT 's prescribed journal format.

Pharmaceutical Biology will publish manuscripts describing the discovery, methods for discovery, description, analysis characterization, and production/isolation (including sources and surveys) of biologically-active chemicals or other substances, drugs, pharmaceutical products, or preparations utilized in systems of traditional medicine.Topics may generally encompass any facet of natural product research related to pharmaceutical biology. Papers dealing with agents or topics related to natural product drugs are also appropriate (e.g., semi-synthetic derivatives). Manuscripts will be published as reviews, perspectives, regular research articles, and short communications. The primary criteria for acceptance and publication are scientific rigor and potential to advance the field.Read More: http://informahealthcare.com/page/phb/Description.

Point of Care: The Journal of Near-Patient Testing & Technology is the only journal entirely devoted to the increasingly significant practice of bedside ancillary testing. This one-of-a-kind quarterly journal is a vital resource for directors and managers of hospital pathology labs...emergency departments...home healthcare agencies...doctors' offices...and other healthcare facilities that use point-of-care testing (POCT).Point of Care is a one-stop guide to the latest technologies, trends, issues, and research in near-patient testing worldwide. The journal delivers must-read news reports, rigorously peer-reviewed studies, and practical advice to help readers use the most efficient and cost-effective laboratory management approaches relating to POCT. Point of Care provides no-holds-barred assessments of specific POCT products8212;from cost-effectiveness, ease of use, and user satisfaction to accuracy and precision of test results and the product's clinical viability. Other articles discuss the limitations of various procedures in ambulatory care settings. Coverage also includes the latest innovations in informatics...reports on changing fee structures...discussions of new regulations...guidelines for implementing quality control procedures...practical pointers for specimen storage and preservation...and much more. Website: www.poctjournal.com.

The objective of the journal is to provide practical information of immediate relevance to workers in clinical laboratories. The primary scope of the journal covers clinical chemistry, hematology, molecular biology and genetics relevant to laboratory medicine, microbiology, immunology, therapeutic drug monitoring and toxicology, laboratory management and informatics.

We welcome papers which describe critical evaluations of biomarkers and their role in the diagnosis and treatment of clinically significant disease, validation of commercial and in-house IVD methods, method comparisons, interference reports, the development of new reagents and reference materials, reference range studies and regulatory compliance reports. Manuscripts describing the development of new methods applicable to laboratory medicine (including point-of-care testing) are particularly encouraged, even if preliminary or small scale.

While novel or innovative work is preferred, papers of a confirmatory nature will also be considered if they are scientifically and technically valid and relevant to important topics.

Chaque mois, la Revue francophone des laboratoires propose a ses lecteurs:toute l'actualité scientifique professionnelle à travers une revue de presse internationale et des échos rédigés par les membres de notre comité scientifique,un dossier scientifique consacré à un thème de fond en biologie médicale, composé d'articles scientifiques de très haut niveau couvrant les différents phénomènes biologiques et les différentes techniques d'analyses,Un dossier du technicien plus "pratique" spécialement destiné à la formation des techniciens de laboratoires,des rubriques régulières comme Cas clinique et Fiche technique illustrant, à partir d'un cas concret, une méthode de diagnostic ou une technique d'analyse,une veille juridique, complément indispensable pour la bonne exécution des analyses.

ranslating Life Sciences Innovation: SLAS Technology explores ways in which scientists adapt advancements in technology for scientific exploration and experimentation.

SLAS Technology emphasizes scientific and technical advances that enable and improve life sciences research and development; drug-delivery; diagnostics; biomedical and molecular imaging; and personalized and precision medicine. This includes high-throughput and other laboratory automation technologies; micro/nanotechnologies; analytical, separation and quantitative techniques; synthetic chemistry and biology; informatics (data analysis, statistics, bio, genomic and chemoinformatics); and more.

SLAS Technology is of particular interest to those involved in automation, bioengineering, micro- and nanotechnology, nanomedicine, microfluidics, 3D printing, biotechnology, bioinformatics, analytical chemistry, biomedical optics, information technology, artificial intelligence, spectroscopy, clinical diagnostics, pharmacogenomics, molecular biology and biomedical sciences.

SLAS Technology is a member of the Committee on Publication Ethics (COPE) and was published previously (1996-2016) as the Journal of Laboratory Automation (JALA).

Each issue of Seminars in Diagnostic Pathology offers current, authoritative reviews of topics in diagnostic anatomic pathology. The Seminars is of interest to pathologists, clinical investigators and physicians in practice.

The Neurodiagnostic Journal is the official journal of ASET - The Neurodiagnostic Society. It is an educational resource for Neurodiagnostic professionals, a vehicle for introducing new techniques, the latest research, innovative technologies, and an avenue for sharing best practices within the Neurodiagnostic profession. The journal features original articles about electroencephalography (EEG), evoked potentials (EP), intraoperative neuromonitoring (IONM), nerve conduction (NC), polysomnography (PSG), autonomic testing, and long-term monitoring (LTM) in the intensive care (ICU) and epilepsy monitoring units (EMU). Subject matter also includes education, training, lab management, legislative and licensure needs, guidelines for standards of care, and the impact of our profession in healthcare and society. The journal seeks to foster ideas, commentary, and news from technologists, physicians, clinicians, managers/leaders, and professional organizations, and to introduce trends and the latest developments in the field of neurodiagnostics. Media reviews, case studies, ASET Annual Conference proceedings, review articles, and quizzes for ASET-CEUs are also published in The Neurodiagnostic Journal.

The core strength of ASET is the talent and experience of its members, and the Editorial Board seeks to showcase that strength in each issue of The Neurodiagnostic Journal. We invite your input, participation, and contribution to the journal so we can continue to provide an invaluable educational resource for our professional community.

Therapeutic Drug Monitoring is an outstanding journal that fosters the exchange of knowledge among the various disciplines--clinical pharmacology, pathology, toxicology, analytical chemistry--that share a common interest in therapeutic drug monitoring. The journal presents studies detailing the various factors that affect the rate and extent drugs are absorbed, metabolized, and excreted. Regular features include review articles on specific classes of drugs; original articles; case reports; technical notes; and continuing education articles.Published BiMonthlyWebsite: www.drug-monitoring.com.

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our http://www.elsevier.com/wps/find/authorsview.authors/authorservicesauthor services.

Please see our http://www.elsevier.com/wps/find/journaldescription.cws_home/709553/authorinstructionsGuide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com